Skip to content

AptarGroup

US · ATR #1713 by market cap Listed 1970
140.08 -0.26 -0.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Below fair value
143.35 fair value ≈ 170.85 198.35
  • Implied fair-value range of 143.35-198.35, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -18.0% below the average-multiple fair value of 170.85.

Valuation each multiple against its own 5-year range

P/B ratio 3.47 Cheap vs history 31st percentile
5-year average 3.68 · #32 of 51 in Medical Instruments & Supplies
P/E ratio 34.56 Expensive vs history 97th percentile
5-year average 29.01 · forward 23.67 · #17 of 27 in Medical Instruments & Supplies
P/S ratio 2.27 In line with history 39th percentile
5-year average 2.41 · forward 2.22 · #21 of 51 in Medical Instruments & Supplies

Vs. peers Medical Instruments & Supplies

Company Market cap P/E (TTM) P/B Div yield
AptarGroup (ATR) 8.88B 33.84 3.40 1.37%
Intuitive Surgical (ISRG) 138.33B 48.25 8.65 0.00%
Becton Dickinson & Co (BDX) 57.96B 52.02 2.35 1.97%
Alcon (ALC) 35.92B 54.24 1.64 0.48%
ResMed (RMD) 33.14B 21.46 5.57 1.04%
Medline (MDLN) 32.55B 57.52 2.76 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★☆ Fair value145.70 Economic moatNarrow UncertaintyLow

Trading 4.0% below Morningstar's fair value estimate.

Fair value

AptarGroup Inc receives a 4-star quantitative star rating, reflecting our opinion that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a minor 2% discount to our quantitative fair value estimate of $145.70 per share, which is reinforced by this estimate's low uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's profitability bolsters our estimated fair value. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its enterprise value to free cash flow ratio of 21.6, which falls in the bottom 45% compared with peers globally. This can be a sign of operational efficiency and potential for the company to fund growth, pay dividends, or reduce debt without needing additional capital. We believe this is a sign that shares could be undervalued.

Conversely, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 28.9%, a core component of valuation, falls in the bottom 30% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

AptarGroup discussion 0 comments

Add a comment